-
Investigating the Role of Lysosomal Biomarker ATP13A2 in the Pathogenesis of Parkinson’s Disease
… of a variety of neurodegenerative diseases, including PD, multiple system atrophy and progressive supranuclear palsy. Additionally, we …
-
A simple, versatile and robust centrifugation-based filtration protocol for the isolation and quantification of α-synuclein monomers, oligomers and fibrils: towards improving experimental reproducibility in α-synuclein research
January 11, 2020
… we describe here a simple centrifugation-based filtration protocol for the isolation, quantification and assessment of … heterogeneous α-syn samples of increasing complexity. The protocol is simple, does not require any special … several examples that illustrate the applications of this protocol and how it could contribute to improving the …
-
Tax Reform Bill Could Impact Research and Care
November 7, 2017
… to make them.) Many of the parkinsonisms , including multiple system atrophy, progressive supranuclear palsy, Lewy body dementia …
-
Episode 10: Understanding Genetics, Pathology, and Progression in Parkinson's Disease and Atypical Parkinsonian Syndromes with Huw Morris
March 5, 2024
… Syndromes, such as progressive supranuclear palsy (PSP), multiple system atrophy (MSA), corticobasal degeneration (CBD), and dementia …
-
Parkinson’s Disease Vaccine Treatment Approach Awarded $8M
April 29, 2014
… developing vaccines against Parkinson’s disease (PD) and multiple system atrophy (MSA). The Michael J. Fox Foundation granted AFFiRiS …
-
Metabolomic Analysis of Parkinsonian Disorders
… confused with PD (progressive supranuclear palsy and multiple system atrophy) will also be studied for constituents in samples of …